Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder The US Food and Drug Administration's Perspective on the New Antipsychotic Pimavanserin PDF $40.00
$40.00
× Placeholder Occurrence and Clinical Correlates of Psychiatric Comorbidity in Patients With Psychotic Disorders PDF $40.00
$40.00
× Placeholder Insomnia and Impaired Quality of Life in the United States PDF $40.00
$40.00
× Placeholder A Preliminary Study of fMRI-Guided rTMS in the Treatment of Generalized Anxiety Disorder PDF $40.00
$40.00
× Placeholder Minimum Clinically Important Difference in the Positive and Negative Syndrome Scale With Data From the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) PDF $40.00
$40.00
× Placeholder Divalproex Sodium for the Treatment of Conduct Disorder: A Randomized Controlled Clinical Trial PDF $40.00
$40.00
× Placeholder Double-Blind, Placebo-Controlled Trial of Topiramate Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $280.00
Total $280.00
Proceed to checkout

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe